23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

Market open

 --Real time quotes

Jan 26, 2022, 9:42 a.m.

ME
/zigman2/quotes/222659849/composite

$

4.48

Change

+0.08 +1.82%

Volume

Volume 85,489

Real time quotes

/zigman2/quotes/222659849/composite

Previous close

$ 4.40

$ 4.48

Change

+0.08 +1.82%

Day low

Day high

$4.47

$4.64

Open

52 week low

52 week high

$3.99

$18.16

Open

Company Description

23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The firm’s re...

23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. It provides direct access to genetic information with multiple Food and Drug Administration authorizations for genetic health risk reports. The firm’s research platform has generated publications on the genetic underpinnings of a range of diseases, conditions, and traits. The platform also powers the 23andMe therapeutics group, pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in Sunnyvale, CA.

Valuation

Price to Book Ratio

1.72

Enterprise Value to EBITDA

-1,842.44

Efficiency

Liquidity

Current Ratio

0.07

Quick Ratio

0.07

Cash Ratio

0.04

Profitability

Capital Structure

Officers and Executives

Name Age Officer Since Title
Ms. Anne E. Wojcicki 46 2006 Chief Executive Officer & Director
Mr. Steven Schoch - 2018 Chief Financial & Accounting Officer
Mr. Steve Lemon 57 2010 Vice President-Engineering
Dr. Joyce Tung 42 2007 Vice President-Research
Dr. L. Okey Onyejekwe 45 - VP-Consumer Clinical Operations & Medical Affairs

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/06/2022 Kathy L. Hibbs
Chief Legal Officer
58,800   Derivative/Non-derivative trans. at $0.42 per share. 24,696
01/05/2022 Steve Lemon
Vice President, Engineering
127,647   Derivative/Non-derivative trans. at $0.23 per share. 29,358
12/03/2021 Sandra Rae Hernández
Director
18,115   Award at $0 per share. 0
12/03/2021 Sandra Rae Hernández
Director
36,231   Award at $0 per share. 0
11/01/2021 Paul D Johnson
VP, General Manager-Consumer
352,004   Award at $0 per share. 0
11/01/2021 Paul D Johnson
VP, General Manager-Consumer
746,213   Award at $0 per share. 0
09/14/2021 Peter J. Taylor
Director
18,421   Award at $0 per share. 0
09/14/2021 Peter J. Taylor
Director
36,842   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
18,421   Award at $0 per share. 0
09/14/2021 Valerie Montgomery Rice
Director
36,842   Award at $0 per share. 0
09/14/2021 Roelof Frederik Botha
Director
18,421   Award at $0 per share. 0
09/14/2021 Richard H. Scheller
Director
18,421   Award at $0 per share. 0
09/14/2021 Patrick Shuao-Fong Chung
Director
18,421   Award at $0 per share. 0
09/14/2021 Neil Mohan
Director
18,421   Award at $0 per share. 0
/news/latest/company/us/me

MarketWatch News on ME

  1. Branson reportedly eyes Amsterdam for first European SPAC

    9:07 a.m. Jan. 7, 2022

    - Steve Goldstein

  2. The S&P 500 Didn't Budge Today. But Bond Yields Popped.

    5:28 p.m. Nov. 15, 2021

    - Barron's Online

  3. 23andMe buys telemedicine specialist Lemonaid Health

    6:20 a.m. Oct. 22, 2021

    - Steve Gelsi

  4. Dow Sees Worst Week In 8 Months. Inflation Trade Sputters.

    3:56 p.m. June 18, 2021

    - Barron's Online

  5. These 3 Firms Could Be the Next SPAC Targets

    2:39 p.m. Feb. 5, 2021

    - Barron's Online

  6. 23andMe to go public via merger with Richard Branson's SPAC VG Acquisition

    7:36 a.m. Feb. 4, 2021

    - Ciara Linnane

  7. 23andMe deal has enterprise value of about $3.5 bln

    7:37 a.m. Feb. 4, 2021

    - Ciara Linnane

  8. Loading more headlines...
/news/nonmarketwatch/company/us/me

Other News on ME

  1. Will SPACs Make a Comeback in 2022?

    6:33 a.m. Dec. 31, 2021

    - Motley Fool

  2. How Covid-19 Changed These Eight People’s Finances

    5:30 a.m. Dec. 25, 2021

    - WSJ Staff

  3. My 3 Favorite Under-the-Radar Healthcare Stocks for 2022

    7:12 a.m. Dec. 21, 2021

    - Motley Fool

  4. 2 Cheap Stocks With 10X Potential to Buy in 2022

    6:21 a.m. Dec. 16, 2021

    - Motley Fool

  5. 3 Top IPO Stocks to Put on Your Watchlist

    7:15 a.m. Dec. 13, 2021

    - Motley Fool

  6. Why 23andMe Stock Dropped 29% in November

    2:21 p.m. Dec. 3, 2021

    - Motley Fool

  7. 23andMe Earmarks Cash From SPAC Deal for Drug Development

    3:53 p.m. Nov. 30, 2021

    - Kristin Broughton

  8. 23andMe announce redemption of all outstanding warrants

    4:26 p.m. Nov. 22, 2021

    - Seeking Alpha

  9. Tracking David Einhorn's Portfolio - Q3 2021 Update

    10:16 p.m. Nov. 17, 2021

    - Seeking Alpha

  10. EMJ Capital Ltd. Buys Generac Holdings Inc, Bill. ...

    9:38 a.m. Nov. 16, 2021

    - GuruFocus.com

  11. Loading more headlines...

At a Glance

23andMe Holding Co.

223 North Mathilda Avenue

Sunnyvale, California 94086

Phone

1 6509386300

Industry

-

Sector

-

Fiscal Year-end

12/2021

Revenue

N/A

Net Income

$-48.60M

Employees

-

/news/pressrelease/company/us/me

Press Releases on ME

  1. Moneta Drills New Gold Discovery at Windjammer

    6:51 a.m. Today

    - Newsfile Corp

  2. Moneta Confirms New Gold Discovery at Halfway

    6:51 a.m. Jan. 12, 2022

    - Newsfile Corp

  3. 23andMe Announces Redemption of All Outstanding Warrants

    4:15 p.m. Nov. 22, 2021

    - GlobeNewswire

  4. 23andMe Reports FY2022 Second Quarter Financial Results

    4:06 p.m. Nov. 10, 2021

    - GlobeNewswire

  5. 23andMe to Present at Upcoming Virtual Healthcare Conferences

    4:30 p.m. Nov. 9, 2021

    - PR Newswire - PRF

  6. Loading more headlines...
Link to MarketWatch's Slice.